Case study from The handbook

Challenging policy inertia for HF diagnosis: The Belgian Charter for Heart Failure

5 September, 2018

Natriuretic peptide (NP) testing is not always reimbursed in Belgium, despite being recommended in European guidelines as an important element of heart failure diagnosis. The Belgian Charter for Heart Failure demands reimbursement for guideline-recommended diagnostic tests as one of the five priorities for policy action. The initiative has been led by leading cardiac organisations and has been signed by 12,000 people to date.

Back to the Project
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .